{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-025445","form_type":"8-K","ticker":"ANEB","cik":"0001815974","company_name":"Anebulo Pharmaceuticals, Inc.","filed_at":"2022-09-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.172814+00:00","generated_at":"2026-06-23T12:10:35.968079+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Anebulo reports Q4 net loss $0.10/share; cash $14.5M; positive Phase 2 data for ANEB-001","bullets":["Q4 fiscal 2022 net loss of $2.3M ($0.10 per share), vs $29.1M ($1.59) in prior year quarter.","Operating expenses Q4 $2.3M; fiscal year $6.8M; cash burn Q4 $2.0M; cash at June 30 $14.5M.","Positive Phase 2 Part A topline: ANEB-001 significantly reduced VAS feeling high (p<0.0001) and improved alertness (p<0.01).","Plan to initiate Part B evaluating lower doses by end of Q3 2022; IND submission for U.S. trials by end of 2022.","Inaugural R&D Day scheduled for September 26, 2022 in New York City; Part B data to be presented."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-025445","json":"https://secwatch.observer/filing/0001493152-22-025445.json","markdown":"https://secwatch.observer/filing/0001493152-22-025445.md","text":"https://secwatch.observer/filing/0001493152-22-025445.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815974/000149315222025445/0001493152-22-025445-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815974/000149315222025445/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T12:10:35.968079+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}